North Cumbria Integrated Care Chooses Alcidion as Preferred EPR Supplier

Alcidion LtdThe trust, which provides hospital and community health care for approximately half a million people, has made a clinically-led decision to use Alcidion's Miya Precision platform. The modular EPR will enhance digital maturity and will support clinicians in the delivery of high quality, safe care for patients.

Intuitive design, ease of use, and interoperability with specialist systems that NCIC wishes to retain, were key benefits recognised by the trust's EPR evaluation team, which represented all services, at all levels, across the trust.

Dr Adrian Clements, executive medical director for NCIC, said: "We are pleased to have selected Alcidion as our preferred EPR provider on what is a significant advancement for North Cumbria in modernising our technological offering to provide a better service and experience for our patients, whilst also significantly increasing our digital maturity as a trust.

"Over the last few months, many of us have spent a great amount of time evaluating the various electronic patient record systems in order to reach the correct conclusion to help us implement the best possible dynamic EPR system. I feel assured and confident that selecting Alcidion will allow us to implement an EPR that enables high quality patient care, improves clinical safety and saves clinicians' valuable time."

NCIC, which already uses Alcidion's PCS patient administration system, provides services across two acute hospitals, eight community-based hospitals, eight integrated care communities, and a number of support staff locations over a large geographical footprint.

Miya Precision's full product suite will enable mobile working, streamline patient flow, support clinical decision-making processes, and will provide clinicians with real-time access to unified patient records.

Kate Quirke, Alcidion group managing director, said: "We are excited to build upon our existing relationship with NCIC as the trust's preferred EPR supplier. Having been the supplier of the trust’s patient administration system for more than eight years, we are now able to continue our relationship by bringing the full Miya Precision capabilities, alongside our partner applications, to deliver a comprehensive electronic patient record, accessible across NCIC.

"Alcidion's integrated, modular EPR solution allows NCIC to develop their existing digital footprint, protecting the trust’s existing investments and allowing healthcare professionals to realise the benefits of additional clinical capabilities, such as electronic noting and integrated observations, through integration with a number of existing systems. At a time when the health service is under enormous pressure, we see this increased speed to deliver value as a real opportunity for our customers."

NCIC is the second trust within the North East and North Cumbria Integrated Care System to choose Alcidion's Miya Precision as its EPR, with other trusts in the region also using technology provided by Alcidion.

Alcidion and NCIC will now finalise what is anticipated to be a 10-year contract, before commencing deployment of Miya Precision, which is targeted to begin in early 2025.

About North Cumbria Integrated Care NHS Foundation Trust

North Cumbria Integrated Care NHS Foundation Trust (NCIC) is part of the North East and North Cumbria Integrated Care System. It provides hospital and community health services to a population of around half a million people and is responsible for delivering over 70 services across 15 main locations; employing over 6,700 members of staff. NCIC was established on 1st October 2019, following the merger of Cumbria Partnership NHS Foundation Trust and North Cumbria University Hospitals NHS Trust. The estate consists of two acute care hospitals, eight community based hospitals, eight Integrated Care Communities (ICC) and a number of support staff locations over a large geographical footprint, working collaboratively with primary care networks, including 39 General Practices and an out of hours GP service.

About Alcidion

Alcidion Group Limited (Alcidion) has a simple purpose, that is, to transform healthcare with proactive, smart, intuitive technology solutions that improve the efficiency and quality of patient care in healthcare organisations, worldwide.

Alcidion offers a complementary set of software products and technical services that create a unique offering in the global healthcare market. Based on the flagship product, Miya Precision, the solutions aggregate meaningful information to centralised dashboards, support interoperability, facilitate communication and task management in clinical and operational settings and deliver Clinical Decision Support at the point of care; all in support of Alcidion’s mission to improve patient outcomes.

Since listing on the ASX in 2011, Alcidion has acquired multiple healthcare IT companies and expanded its foothold in the UK, Australia, and New Zealand to now service over 400 hospitals and 87 healthcare organisations, with further geographical expansion planned.

With over 20 years of healthcare experience, Alcidion brings together the very best in technology and market knowledge to deliver solutions that make healthcare better for everyone.

Most Popular Now

AI System Helps Doctors Identify Patient…

A new study from Vanderbilt University Medical Center shows that clinical alerts driven by artificial intelligence (AI) can help doctors identify patients at risk for suicide, potentially improving prevention efforts...

Smartphone App can Help Reduce Opioid Us…

Patients with opioid use disorder can reduce their days of opioid use and stay in treatment longer when using a smartphone app as supportive therapy in combination with medication, a...

AI's New Move: Transforming Skin Ca…

Pioneering research has unveiled a powerful new tool in the fight against skin cancer, combining cutting-edge artificial intelligence (AI) with deep learning to enhance the precision of skin lesion classification...

Predicting the Progression of Autoimmune…

Autoimmune diseases, where the immune system mistakenly attacks the body's own healthy cells and tissues, often have a preclinical stage before diagnosis that’s characterized by mild symptoms or certain antibodies...

AI can Improve Ovarian Cancer Diagnoses

A new international study led by researchers at Karolinska Institutet in Sweden shows that AI-based models can outperform human experts at identifying ovarian cancer in ultrasound images. The study is...

Major EU Project to Investigate Societal…

A new €3 million EU research project led by University College Dublin (UCD) Centre for Digital Policy will explore the benefits and risks of Artificial Intelligence (AI) from a societal...

Using AI to Uncover Hospital Patients�…

Across the United States, no hospital is the same. Equipment, staffing, technical capabilities, and patient populations can all differ. So, while the profiles developed for people with common conditions may...

New AI Tool Uses Routine Blood Tests to …

Doctors around the world may soon have access to a new tool that could better predict whether individual cancer patients will benefit from immune checkpoint inhibitors - a type of...

New Method Tracks the 'Learning Cur…

Introducing Annotatability - a powerful new framework to address a major challenge in biological research by examining how artificial neural networks learn to label genomic data. Genomic datasets often contain...

Picking the Right Doctor? AI could Help

Years ago, as she sat in waiting rooms, Maytal Saar-Tsechansky began to wonder how people chose a good doctor when they had no way of knowing a doctor's track record...

From Text to Structured Information Secu…

Artificial intelligence (AI) and above all large language models (LLMs), which also form the basis for ChatGPT, are increasingly in demand in hospitals. However, patient data must always be protected...

AI Innovation Unlocks Non-Surgical Way t…

Researchers have developed an artificial intelligence (AI) model to detect the spread of metastatic brain cancer using MRI scans, offering insights into patients’ cancer without aggressive surgery. The proof-of-concept study, co-led...